060 633 2512

July 28, 2014

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

The widely used antiretroviral drug efavirenz was not linked with neurocognitive impairment in a study reported this week at AIDS 2014. Efavirenz (Sustiva, also part of the popular Atripla combo pill) has been associated with a variety of neuropsychiatric symptoms ranging from vivid dreams to depression, but whether the drug contributes to neurocognitive impairment (NCI) has been debated.